This company listing is no longer active
Yumanity Therapeutics Management
Management criteria checks 1/4
Key information
Richard Peters
Chief executive officer
US$4.5m
Total compensation
| CEO salary percentage | 13.8% |
| CEO tenure | 2yrs |
| CEO ownership | n/a |
| Management average tenure | 2yrs |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$32m |
| Jun 30 2022 | n/a | n/a | -US$39m |
| Mar 31 2022 | n/a | n/a | -US$44m |
| Dec 31 2021 | US$4m | US$618k | -US$40m |
Compensation vs Market: Richard's total compensation ($USD4.49M) is above average for companies of similar size in the German market ($USD433.49K).
Compensation vs Earnings: Insufficient data to compare Richard's compensation with company performance.
CEO
Richard Peters (59 yo)
2yrs
Tenure
US$4,494,240
Compensation
Dr. Richard Peters, M.D., Ph D., is a Founder at X4 Pharmaceuticals, Inc. He serves as Independent Director at Aprea Therapeutics AB since July 2020. He served as Director of PIC Therapeutics Inc. He Co-Fo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2yrs | US$4.49m | no data | |
| Scientific Co-Founder & Senior Advisor of Discovery Biology | 5.1yrs | no data | no data | |
| Scientific Co-Founder & Associate Director of Discovery Biology | 5.1yrs | no data | no data | |
| Vice President of Finance | no data | no data | no data | |
| SVP, CFO & Treasurer | 1.3yrs | no data | no data | |
| SVP, General Counsel & Secretary | 1.5yrs | no data | no data |
2.0yrs
Average Tenure
54yo
Average Age
Experienced Management: 8IY's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2yrs | US$4.49m | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2yrs | US$198.30k | no data | |
| Non-Executive Chairman | 2yrs | US$1.53m | no data | |
| Lead Independent Director | 2yrs | US$242.35k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2yrs | US$209.80k | no data | |
| Independent Director | 2yrs | US$194.80k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
2.0yrs
Average Tenure
62.5yo
Average Age
Experienced Board: 8IY's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.